nonprofit logo

Drug Strategies

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 521837390 ✦ Washington, DC ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Drug Strategies?

Drug Strategies is a nonprofit organization headquartered in Washington D.C., specifically at 2101 L Street NW 800. Their primary focus is addressing the escalating drug overdose crisis in the United States, particularly driven by the opioid fentanyl. In 2021 alone, over 100,000 drug overdose deaths were reported, and this trend continues to rise. Recognizing the urgency of prevention and treatment efforts, Drug Strategies works to promote more effective approaches to the nation's drug problems. They support private and public initiatives that reduce drug demand through various means, including prevention, education, treatment, law enforcement, and community initiatives. With a small team of one dedicated individual, Drug Strategies is committed to making a difference in the fight against the drug overdose epidemic.


Official website here: www.drugstrategies.com

What are the reviews and ratings of this charity?

Charity Navigator Rating: 97% (Four-Star out of Four Stars)

Drug Strategies has earned a Four-Star rating from Charity Navigator, reflecting an impressive score of 97%. This high rating indicates a strong emphasis on accountability and finance, with the organization's performance assessed solely on these metrics. The charity demonstrates exemplary governance with 87% of its board members being independent, ensuring that decisions are made in the best interest of the organization and its mission.

The financial health of Drug Strategies is robust, highlighted by a low liabilities to assets ratio of 4.28% and a program expense ratio of 78.70%. This means a significant majority of their expenses contribute directly to their programs, maximizing the impact of donor contributions. The presence of policies regarding conflicts of interest, whistleblowing, and document retention further solidifies the organization’s commitment to transparency and ethical operations.

There are no noted limitations in the data regarding Drug Strategies, which presents a strong and well-managed nonprofit focused on its objectives. Overall, the organization exemplifies effective practices in governance and financial management, fostering trust and accountability among its stakeholders.


This AI summary has been generated from information found on Charity Navigator.

Is Drug Strategies legitimate?

Drug Strategies is a legitimate nonprofit organization registered as a 501(c)(3) entity. Drug Strategies submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $105,666
Professional Fundraising Fees: $0
Other Salaries and Wages: $0

For more financial information, click here


Official website here: www.drugstrategies.com

What is the mission statement of Drug Strategies?

Drug Strategies, as an organization, aims to promote more effective approaches to the nation's drug problems. They achieve this by supporting both private and public efforts to reduce the demand for drugs through various means. These methods include prevention, education, treatment, law enforcement, and community initiatives. The primary focus of Drug Strategies is to address the current overdose epidemic in the U.S., particularly driven by fentanyl. In 2021, over 100,000 drug overdose deaths were reported, and efforts to prevent and treat this issue are deemed urgent.


Official website here: www.drugstrategies.com

Who is the CEO of Drug Strategies?

Mathea Falco is the Director of Drug Strategies.


Official website here: www.drugstrategies.com

What is the revenue of Drug Strategies?

Drug Strategies's revenue in 2022 was $182,093.


Official website here: www.drugstrategies.com

Who are the executives of Drug Strategies and what are their salaries?

The average compensation at Drug Strategies during 2022 was $105,666. There is 1 employee at Drug Strategies.


Here are 8 key members and their salaries:


Marian Wright Edelman (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Louise Bryson (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Morris Panner (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Michael Kantor (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Ambassador James R Jones (Board Chair)
  • Compensation: $0
  • Related: $0
  • Other: $0
Marni Vliet (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr A Thomas Mclellan (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mathea Falco (Executive Director/Preside)
  • Compensation: $38,800
  • Related: $0
  • Other: $66,866


Official website here: www.drugstrategies.com

Where can I find the form 990 for Drug Strategies?

Drug Strategies's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.drugstrategies.com

Learn more at the official website: www.drugstrategies.com

Mission Statement of Drug Strategies

Drug Strategies, a prominent organization, is dedicated to promoting more efficient solutions to the nation's drug issues. Their mission is multifaceted, encompassing the support of private and public initiatives aimed at decreasing drug demand. They achieve this through various means, including prevention, education, treatment, law enforcement, and community-based programs. The organization's primary focus at present is addressing the current overdose epidemic in the United States, largely fueled by fentanyl. In 2021, over 100,000 drug overdose deaths were reported, and this number continues to ascend, underscoring the urgent need for more preventative and therapeutic measures.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Drug Strategies plays a crucial role in addressing the ongoing overdose epidemic in the United States, primarily influenced by the widespread abuse of opioid fentanyl. With over 100,000 reported drug overdose deaths in 2021 alone, the urgent demand for effective prevention and treatment strategies has never been clearer. By advocating for comprehensive approaches, Drug Strategies enhances public understanding of drug issues and emphasizes the importance of education, prevention, and community initiatives.

Their efforts contribute to strengthening both private and public sector responses to drug-related challenges, fostering collaboration among stakeholders, and ultimately aiming to reduce the demand for drugs. Through these initiatives, Drug Strategies seeks not only to mitigate immediate crises but also to pave the way for long-term solutions that improve community health and safety. The organization’s focus on evidence-based strategies and holistic responses underscores the importance of a multifaceted approach to the nation’s drug problems, directly impacting the quality of life for countless individuals and families affected by addiction.




This information is meant to be a general summary of Drug Strategies. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$182,093 (2022)
Expenses
$284,100 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $82,040
  • Gross Receipts: $286,697

Assets and Liabilities:

  • Total Assets: $462,658
  • Total Liabilities: $32,587
  • Net Assets: $430,071

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

1993

Principal Officer

Mathea Falco

Main Address

2101 L STREET NW 800, WASHINGTON, DC, 20037

NTEE Category

Code: W20Z - Public benefit

If you are a representative of Drug Strategies and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.